on chr15q21.2-22.3. This peak included NEDD4, a gene previously implicated in a keloid genome-wide association study (GWAS) of Japanese individuals later validated in a Chinese cohort. While we observed modest evidence for association with NEDD4, a more significant association was observed at (myosin 1E) MYO1E. A genome scan not including the 15q21-22 region also identified associations at MYO7A (rs35641839, odds ratio [OR] = 4.71, 95 % confidence interval [CI] 2.38-9.32, p = 8.34 × 10 −6 ) at 11q13.5. The identification of SNPs in two myosin genes strongly associated with keloid formation suggests that an altered cytoskeleton contributes to the enhanced migratory and invasive properties of keloid fibroblasts. Our findings support the admixture mapping approach for the study of keloid risk, and indicate potentially common genetic elements on chr15q21.2-22.3 in causation of keloids in AAs, Japanese, and Chinese populations.
Introduction
Keloids are benign fibrotic tumors of the dermis that form during a prolonged wound healing process (Marneros et al. 2004; Niessen et al. 1999) . They are characterized by expansion beyond the bounds of the original wound, invading surrounding normal skin (references cited in Bond et al. 2011) . Keloids have been estimated to occur in ~1/30 African Americans (AAs) and ~1/625 of the overall US population (Barrett 1973) . Keloid formation is one of a group of fibroproliferative diseases characterized by an exaggerated response to injury that occurs at higher frequency or with more severe manifestations in people of African descent (Smith et al. 2008) . These diseases include hypertension, nephrosclerosis, scleroderma, sarcoidosis, allergic disease, and uterine fibroma. We and others have suggested that a common etiopathology may operate in these diseases, and that common genetic factors may account for their unusual racial distribution (references cited in Smith et al. 2008) . The key alteration(s) responsible for the pathological processes resulting in keloid formation has not been identified, and there is no satisfactory treatment for this disorder.
While most cases of keloid formation occur sporadically, familial forms have been observed. The hypothesis of a genetic component for keloid formation is supported by the occurrence of keloids at different frequencies in different ancestral populations, regardless of current location. Although some cases of keloid formation may be due to somatic mutation (Saed et al. 1998) , multiple keloids in the same individual and evidence for a multicellular origin of keloids argue against somatic mutation as the primary event in most cases (Chevray and Manson 2004; MoultonLevy et al. 1984; Trupin et al. 1977 ). There have been several studies attempting to identify the genetic basis of keloids. Linkage studies have been performed in both AA and Japanese. The AA studies identified loci at 14q22-q23 (Davis et al. 2000) , and 7p11 (1), whereas linkage to 2q23 was found in Japanese (Marneros et al. 2004) . None of these studies, however, was able to localize the linkage signal. A recent genome-wide association study (GWAS) in a Japanese population identified four single-nucleotide polymorphism (SNP) loci in three chromosomal regions (1q41, 3q22.3-23 and 15q21.3) that showed significant association with keloid formation (Nakashima et al. 2010) . The results from this study were independently replicated in a Chinese population (Zhu et al. 2013) . From the limited data available in the above studies and in pedigrees supporting autosomal dominant inheritance with reduced penetrance, genetic complexity is indicated for keloids, consistent with contributions of multiple susceptibility loci, each of which may provide a different genetic model of disease risk.
The approximate 20-fold increase observed for keloid formation in AA relative to European American (EA) in the US indicates that an alternative approach to identifying keloid loci, admixture mapping, is likely to yield informative results. While admixture mapping has been used in studies of several disorders that occur more frequently in individuals of African ancestry, including asthma (Flores et al. 2012) , hypertension (Zhu et al. 2005) , and nondiabetic end-stage kidney disease (ESKD) (Winkler et al. 2010) , it is potentially even more powerful for mapping keloid loci, given the greater prevalence differential between AAs and EAs. Therefore, in the present study we used admixture mapping together with whole-exome association analysis of keloids in an AA population. The goals of this study are to identify the genetic determinants of keloid formation in an AA population.
Materials and methods

Study populations
This study used AA keloid cases and controls currently available from the BioVU DNA Repository (or BioVU), as well as samples from previously collected keloid fibroblasts and lymphocytes for both admixture mapping and whole-exome association analyses (Russell et al. 2010; Smith et al. 2008) . The study included DNA from 71 AA keloid cases and 364 controls from the BioVU DNA Repository (BioVU, 2007-present) , Vanderbilt University, Nashville, TN. BioVU was designed to link clinical data available from de-identified electronic medical records (EMR) to DNA specimens. BioVU consists of de-identified blood samples obtained from patients at the Vanderbilt University Medical Center Hospital, including all clinics that are part of the hospital system (Pulley et al. 2010) . De-identified data from multiple sources are available within BioVU, including diagnostic and procedure codes (International Classification of Diseases 9th edition and current procedural terminology [CPT]), basic demographics, discharge summaries, nursing notes, progress notes, health history, multi-disciplinary assessments, laboratory values, echocardiogram diagnoses, imaging reports, electronically derived data, and inpatient medication orders. BioVU keloid cases were defined as AAs 18 years or older who were diagnosed with keloids in the EMR and who have at least two mentions of a keloid diagnosis in their record (either two diagnostic codes [ICD 9 = 701.4] or a code and mention of a keloid within their record). Controls were AA subjects 18 years and older who have had surgical procedures performed at the Vanderbilt University Medical Center Hospital that involved an open wound, such as breast surgery, cesarean section and open heart surgery, and have 2 years of follow-up in the EMR with no evidence of keloid formation. Excluded from controls are individuals with either a diagnosis of keloids (ICD9 = 701.4) or other fibroproliferative disorders such as asthma (ICD9 = 493*), nephrosclerosis (ICD9 = 403.90), or fibroids (ICD9 = 68.2, 68.29, 218*, 654.1*; CPT = 58,140). Also, excluded from controls are individuals with the keywords "excessive scarring" in their clinical record. While individuals with keloids are not more susceptible to these conditions than the general population, common susceptibility variants may be present. Initial validation analyses via manual review of records by DRVE and SBR demonstrated that the phenotyping algorithms were able to accurately capture cases and controls. A detailed description of the human subjects protection applied to BioVU is described by Pulley et al. (2010) .
Keloid cases (n = 36) were also obtained from a keloid biospecimen repository (15-53 years) that includes collection of cultured fibroblasts from normal and keloid scar tissue (5, 17). The diagnosis was made both by the surgeon or dermatologist removing the tissue and by the pathologist who examined the tissue. The principal criterion used to differentiate keloid from other hypertrophic scars was the extent to which the scar exceeded the boundary of the initiating wound. The majority of specimens met three additional criteria that help to differentiate keloids from other hypertrophic scars: (1) the patient has multiple keloids; (2) tumors have recurred following surgical removal or other treatment; (3) they do not spontaneously regress over long periods of time. DNA was also obtained from another repository of blood samples of unrelated individuals (n = 21) who were part of multiplex families. These studies were approved by the Vanderbilt University Institutional Review Board, and qualified as exempt non-human subjects research.
DNA extraction and genotyping
All DNA samples were isolated from whole blood or from fibroblasts using the Autopure LS system (QIAGEN Inc., Valencia, CA).
Genomic DNA was quantitated via an ND-8000 spectrophotometer and DNA quality was evaluated via gel electrophoresis. We genotyped DNA from the 494 participants using the custom Affymetrix Axiom Exome Genotyping Array (Affymetrix Inc., Santa Clara, CA). The genomic DNA samples were processed according to standard Affymetrix procedures for processing of the assay. The data were processed for genotype calling using the Affymetrix Power Tools software (APT, Affymetrix Inc., Santa Clara, CA).
Microarray data
We used previously published microarray data to evaluate associations located under the admixture mapping peak (Smith et al. 2008) . Methods describing isolation and propagation of fibroblasts from keloids and normal scars and microarray analysis approaches have been previously described (Russell et al. 1978; Smith et al. 2008 ).
Whole-exome genotyping study quality control Data on 319,283 SNPs and 492 individuals were available prior to implementation of quality control. Six individuals were removed after excluding individuals with low genotyping efficiency (<95 %). Three subjects were removed due to inconsistencies between reported sex and genetically estimated sex. Five individuals were removed after kinship estimates identified related individuals using identity-bydescent sharing from a random selection of 100,000 autosomal SNPs. When a pair of related individuals was identified, only one member (parent or sibling) of the family was included, with priority given to parent over offspring. 478 unrelated women remained in the final dataset.
All SNPs were tested for deviation from Hardy-Weinberg equilibrium (HWE) using PLINK software (Purcell et al. 2007 ). We excluded SNPs with HWE p ≤ 1.0 × 10 −6 , dropping 498 SNPs. Markers with low genotyping efficiency (<95 %) were also excluded; 5,216 SNPs. Twenty duplicate SNPs, 146 non-autosomal SNPs and 149,790 monomorphic SNPs were removed. Quality control procedures are outlined in Supplemental Fig. 1 . After removing subjects and SNPs for quality control, 478 subjects (122 cases and 356 controls) and 163,613 SNPs remained for analyses. Due to our sample size, we limited association analyses to SNPs with an MAF ≥0.05 (47,599 SNPs).
To assess population stratification among AAs samples, EIGENSTRAT software (Price et al. 2006 ) was used to estimate continuous axes of ancestry. The top ten principle components (PCs) were extracted and used as covariates in regression models to test for ancestry and genotype associations (Supplemental Fig. 2 ).
Statistical analyses
Descriptive statistics of demographic data were expressed as means and standard deviations for continuous covariates and as frequencies and proportions for categorical data, and compared between cases and controls with logistic regression using STATA 11.0 statistical software (College Station, TX).
Admixture mapping was performed using whole-exome genotyping data. Admixture mapping has been shown to be a valid approach to identify novel gene regions of interest in studies of several complex diseases (Anum et al. 2009; Cooper et al. 2008; Rosenberg et al. 2010; Zhu et al. 2005) . Admixture mapping were performed using Local Ancestry in Admixed Populations-Ancestry (LAMP-ANC), which uses the ancestral frequencies to infer the ancestral origins of each observed allele for every SNP. For our analyses, we used African ancestry and European ancestry allele frequency estimates from the 1000 Genomes reference populations (September 2013 release). LAMP-ANC was used to identify unlinked markers using r 2 = 0.10 regardless of allele frequency, resulting in 36,344 SNPs available for analyses. LAMP computes the structure of ancestry using overlapping windows of contiguous SNPs and combines the results with estimates of ancestry for a region (Sankararaman et al. 2008) . Admixture mapping association analyses were performed in PLINK using logistic regression with variables coding for 0, 1, or 2 European ancestry chromosomes inferred from SNP genotypes by LAMP-ANC, adjusting for the top 10 PCs and sex. The significance threshold of for the admixture mapping analyses was calculated from n = 1,000 permutations. Permutation testing was conducted by permuting the phenotype to obtain an empirical p value.
Association analyses were conducted on genotyped SNPs for the global whole-exome analysis and for genotyped and imputed SNPs within the genomic region with the strongest evidence from admixture mapping. Common variants, minor allele frequency (MAF) ≥0.05, were analyzed for single SNP association with keloid risk in AAs using logistic regression adjusted for sex and 10 PCs using PLINK software (Purcell et al. 2007 ). Analyses were performed assuming an additive genotypic model. We performed a Bonferroni correction adjusting for the total number of markers that passed QC (0.05/47,599 SNPs = 1.05 × 10
−6
). We used IMPUTE software to impute ungenotyped SNPs in the chromosomal region where we observed the strongest evidence from admixture mapping (chr15q21.2-22.3), using the entire panel from 1000 Genomes reference population (build 37, 2013) (Howie et al. 2009 ). Studies have shown that using the entire reference panel increases imputation accuracy (Howie et al. 2011) . SNPTEST statistical software was used to test imputed SNPs for association with keloids, adjusting for sex and 10 PCs (Marchini et al. 2007 ). Analyses were performed assuming an additive genotypic model.
We also evaluated the strongest associated SNPs through conditional analyses, where we tested for single SNP association at each SNP again adjusting for top PCs, sex, and the top associated index SNP within the region. We also performed secondary analyses of SNP association, accounting for admixture mapping evidence using the approach described by Zhu et al. (2011) . We further analyzed the Spearman rho correlation coefficients between the SNPs evaluated through conditional analyses and then reported r 2 between SNPs evaluated.
Results
Four hundred and seventy eight AA subjects were evaluated by admixture mapping (122 cases and 356 controls) by LAMP-ANC. The majority of subjects were female (70 % cases and 62 % controls) ( Table 1 ). The mean age of study participants was 43 (standard deviation [SD] = 17) for cases and 52 (SD = 18) controls. AA keloid cases on average had a significantly lower proportion European ancestry (19 %) than controls (21 %) (p = 0.011).
Admixture mapping and single SNP association under identified regions
The most significant admixture mapping peak was observed on chromosome 15(q21.2 to 22.3); therefore, we focused our analyses of SNP associations to this region (Fig. 1) . The most significant p values for SNPs within this region from the admixture mapping analyses (association of SNPs with differences in percentage European ancestry across keloid cases and controls) were for myosin 1E (MYO1E, rs140447165), cyclin B2 (CCNB2, rs28383563), glucosaminyl (N-acetyl) transferase 3, Table 1 ). Also of note, a SNP in neural precursor cell expressed, developmentally down-regulated 4, E2 ubiquitin protein ligase (NEDD4) a gene previously implicated in the prior keloid GWAS within a Japanese population (Nakashima et al. 2010) had an admixture mapping analysis p value of 2.73 × 10 −4 . We further evaluated SNPs within one −log 10 (p) of the smallest p values from admixture mapping analyses (p value limit = 1.13 × 10 −3 ) using single SNP association with keloid status. To more comprehensively evaluate the region, we also imputed ungenotyped SNPs within chr15q21.2-22.3 using IMPUTE2 software (Howie et al. 2009 ). Genes located under the admixture mapping peak along with the −log 10 (p) from the single SNP association analyses within this region are shown in Fig. 2 . Although we did see evidence of association in NEDD4 (smallest p = 3 × 10 −5 ), along with other genes associated with fibroproliferative disorders in prior studies, including aldehyde dehydrogenase 1 family, member A2 (ALDH1A2, smallest p = 9 × 10 −3 ), aquaporin 9 (AQP9, smallest p = 3 × 10 −3 ), ring finger protein 111 (RNF111, smallest p = 8 × 10 , Table 2 ). As seen in Fig. 3 , there is good agreement on the involvement of genes at 15q21.2-22.3 from both admixture mapping and single SNP association within the region.
Global whole-exome association
In addition to admixture mapping and tests of single SNP associations with imputation under the 15q peak, we conducted agnostic tests of association of all genotyped SNPs. Strong associations were shown at multiple SNPs in the myosin VIIA (MYO7A) gene located on chromosome 11q13.5, most significant association at rs35641839 (OR = 4.71, 95 % CI 2.38-9.32, p = 8.34 × 10 −6 ) and one at chromosome 4q31.21 SNP in the gene inositol polyphosphate-4-phosphatase, type II, 105 kDa (INPP4B, rs2636675, OR = 3.23, 95 % CI 1.89-5.54, p = 1.97 × 10 −5 ) ( Table 3) . Two of the top associated SNPs in MYO7A are missense mutations (rs35641839 and rs111033183) and one is a synonymous mutation (rs78871677). 
Conditional analyses
Conditional analyses were performed conditioning on the index SNP (most statistically significant association) within a region (Table 4) . We performed conditional analyses for top associated SNPs within chr15q21.2-22.3 with the MYO1E SNP rs747722 as the index SNP and for the global scan using the MYO7A SNP rs35641839 as the index SNP.
These analyses show that the associations within MYO1E are due to rs747722; however, there are independent association signals for NEDD4 and the other intergenic SNPs within chr15q21.2-22.3. Conditional analyses of MYO7A SNPs showed that the signal for MYO7A SNPs was due to rs35641839. A summary of the r 2 between the SNPs evaluated in conditional analyses is provided in Supplemental Table 3 . In a secondary analyses, conditioning admixture mapping analyses on the strongest associated SNP from association analyses (rs747722) none of the SNPs in Supplemental Table 1 were statistically significant (p < 0.05), suggesting that the association between rs747722 and keloids accounts for the evidence observed in admixture mapping analyses.
Discussion
We observed strong evidence of local ancestry associating with keloid risk on chr15q21.2 to 22.3, a region that includes a gene previously associated in a keloid GWAS of Japanese (Nakashima et al. 2010) . Other GWAS have implicated this chromosomal locus with three other fibroproliferative diseases, hypertension in AAs (Adeyemo et al. 2009 ), asthma in a European population (Moffatt et al. 2010) , and atherosclerosis in Finland (Inouye et al. 2012) . A summary of SNPs implicated with fibroproliferative disorders within this genomic region is provided in Table 5 . Significant associations were seen in NEDD4 in keloids, ALDH2 in hypertension, RORA in asthma, and AQP9, CCNB2, RNF11, and MYO1E in atherosclerosis.
Examination of data from an earlier microarray study of fibroblasts from keloids and normal scars, which included some of the subjects evaluated in the admixture mapping and exome association analyses, revealed altered expression of several genes under the admixture mapping peak on chr15q21.2 to 22.3 (Table 6 ), including increased expression for MYO1E and ADAM10 and decreased expression for TCF12 and CCNB2 in keloid versus normal scar fibroblasts (Russell et al. 1978; Smith et al. 2008) . Of interest was the observation of increased expression of ADAM10 only in cultures grown with hydrocortisone, a condition we have shown to downregulate a subset of fibrosis related genes in normal but not keloid fibroblasts.
The most significant association with keloid formation at 15q22.2 was within the MYO1E gene. MYO1E is a widely expressed non-muscle membrane-associated class I myosin with a motor-head domain that binds ATP and F-actin, a calmodulin-binding neck domain, and a long tail consisting of a plasma membrane-binding domain, a proline-rich TH2 domain and a C-terminal SH3 domain (Mele et al. 2011) . Mutations in this gene have been identified as the cause of some cases of focal segmental glomerulosclerosis, a genetically heterogeneous fibroproliferative disease (Butler et al. 2008) . It is involved in multiple actin-dependent processes at the cell membrane including cell migration, cell adhesion and clathrin-mediated endocytosis (Bond et al. 2011; Cheng et al. 2012) . Recently, MYO1E has been shown to be a crucial component of the invadosome, a specialized structure involved in matrix degradation and invasion that may have implications for wound healing. These findings suggest that mutations in the MYO1E gene are excellent candidates for a role in the increased migration and invasive properties of keloid fibroblasts (Bond et al. 2011) . Our previous observation of increased expression of MYO1E in keloid fibroblasts further supports a functional role for this gene (Smith et al. 2008) . Our findings that several genes, including MYO1E, CCNB2 and ADAM10, were significantly associated with keloid formation in three different analyses (admixture, exome association, and gene expression) strengthen the possibility that one or more of these are keloid susceptibility loci. We note that CCNB2 and MYO1E are within 11 kb from each other.
The most significant associations we observed across the genome, excluding 15q21.2-22.3, were from SNPs in another unconventional myosin gene, MYO7A at 11q13.5, two of which were missense mutations. The gene region where the associated SNPs are located is highly conserved across vertebrate species. The SNPs that associated with keloids in MYO7A are only variable in African ancestry individuals according to HapMap reference populations (YRI and ASW) and are located in a regulatory region of the MYO7A gene. The presence of a risk increasing allele only existing in the African populations is consistent with variants at this locus contributing to the observed ancestral prevalence disparity and provides further reason to argue that this is not a false positive finding, especially since this gene was not found 1 3 in the admixture analyses. Defects in the MY07A gene have associated with the mouse shaker-1 phenotype and human skin pigmentation (Fernandez et al. 2009 ). Furthermore, the top associated SNPs (rs35641839) and nearby SNPs have been associated with Usher syndrome, hearing loss, and retinitis pigmentosa (Liu et al. 1998; Roux et al. 2006) . How these conditions may be related to keloids is unclear but the associations with several biologically related traits support the possibility of common biological mechanisms. The GWAS of keloids in a Japanese population (Nakashima et al. 2010 ) found significant associations of four loci in three chromosomal regions, 1q41, 3q22.3-23 and 15q21.3 with keloid formation. The association observed at 15q21.3 was in NEDD4, rs8032158 (OR 1.51, 95 % CI 1.35-1.69, p 5.96 × 10 −13 ). It is of note that within the Japanese population of the HapMap NEDD4 rs8032158 is in a large LD block (99 kb) and is in very strong LD with multiple SNPs within the gene, in contrast to African Americans who have much weaker LD in this region. The results from this study were independently replicated in a Chinese population (Zhu et al. 2013 ). Although we did observe some evidence of association (p < 0.05) within this gene, they were not among our most statistically significant associations (Supplemental Table 1 ). It may be that the association signal observed at NEDD4 in Asians is due to SNPs in the gene being in linkage disequilibrium (LD) with the causal variant(s) elsewhere in the region and not actually being in NEDD4. Alternatively, NEDD4 causative variants may not be captured well by the exome chip platform. It may also be that the effect of NEDD4 is strongest among the Japanese population based on other interacting factors.
Although our study identified several SNPs associated with keloid risk, we were limited by our sample size; we were not powered to identify associations with smaller effect sizes or associations with SNPs with low allele frequencies. As a result, we were unable to use several of the SNPs included on the exome chip. Use of exome chip data also resulted in fewer markers being included in admixture mapping analyses compared to admixture mapping with GWAS data. Furthermore, although we were able to adjust for sex as a covariate, we were unable to adjust for a larger set of potential confounders for the statistical analyses due to poor capture of those variables across all samples. We also note that although our EMR control algorithm was validated after chart review, it is possible that physicians may underreport keloids. However, if keloids were underreported this would only serve to decrease our power and result in weaker risk estimates for our associations, implying that the reported associations are likely stronger than presented. Finally, although we detected statistically significant associations at multiple chromosomal regions (Tables 2, 3) , none of the associations passed the Bonferroni multiple testing correction (p < 1.05 × 10 −6 ). We note that there is no established threshold for multiple testing for whole-exome analyses. We expect this threshold was conservative due to a lack of independence between SNPs in LD. Therefore, it is possible that some of our associations would meet genomewide significance if we accounted for the actual number of independent tests performed and not the conventional threshold. However, we emphasize the need to replicate our study findings.
In summary, we evaluated whole-exome genotyping data for evidence of local ancestry associating with risk of keloids and observed strong evidence of association in several genes, including from gene expression data. The finding that African ancestry at 15q21.2-22.3 was strongly associated with keloids is the first evidence of this type in AAs and points toward common elements in the genetics of keloids in African and Asian populations. GWAS and other studies implicating chromosomal region 15q21.2-22.3 in multiple fibroproliferative diseases with identification of different associating genes accentuate the importance of the region, but also the need for additional studies to validate findings and to identify causal variants. Lastly, the identification of SNPs in two different myosin genes that are strongly associated with keloid formation suggests that an altered cytoskeleton contributes to the enhanced migratory and invasive properties of keloid fibroblasts. 
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